KIDNEY DAMAGE IN CHILDREN WITH COVID-19 (CLINICAL CASE)

2021

Full text Open access: Hybrid Metadata (CSL-JSON)
DOI 10.31618/essa.2782-1994.2021.2.73.123
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Currently, in the study of the SARS-COV-2 (COVID-19) viral infection, the issues of the course and outcome of the disease are becoming increasingly important. Thanks to the implementation of the COVID-19 Diagnostic and Treatment Protocols, it was possible to establish control over the timely diagnosis and optimization of the unfavorable outcome of a new viral infection.The lower prevalence and severity of the disease in children may be associated with both a lower susceptibility to COVID-19 infection and a lower likelihood of symptoms. The role of neutropenia characteristic of childhood cannot be ruled out.However, recent studies indicate an increase in the incidence of COVID-19 among children. Attention is drawn to kidney damage in this syndrome, where the development of acute renal damage with the subsequent development of multiple organ syndrome can affect the outcome of COVID-19.